Prognostic value of DNA cytometry in patients with non-small cell lung carcinoma

被引:0
|
作者
Skuballa, A [1 ]
Starke, U [1 ]
Achatzy, R [1 ]
Hutschenreiter, J [1 ]
机构
[1] Stadt Klinikum St Georg, Klin Thoraxchirurg, Leipzig, Germany
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
DNA flow cytometry;was used to study ploidy and cell cycle phase in patients with non - small cell lung carcinoma. A total number of 80 tumor samples were investigated. Cell cycle analysys was possible in 42 tumors. 79% of the tumors were aneuploid and 21% had diploid tumors. There was a correlation between high S-phase fraction in aneuploid tumors and lower S-phase fraction in diploid tumors. Patients with a lower S-phase fraction had a tendency to better survival, both diploid and aneuploid tumors.
引用
收藏
页码:89 / 92
页数:4
相关论文
共 50 条
  • [41] The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma
    Al-Shibli, Khalid
    Al-Saad, Samer
    Donnem, Tom
    Persson, Magnus
    Bremnes, Roy M.
    Busund, Lill-Tove
    HISTOPATHOLOGY, 2009, 55 (03) : 301 - 312
  • [42] The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma
    Al-Shibli, Ibrahim K.
    Al-Saad, S.
    Donnem, T.
    Persson, M.
    Bremnes, R.
    Busund, L.
    VIRCHOWS ARCHIV, 2009, 455 : 85 - 85
  • [43] The Prognostic Value of Intraepithelial and Stromal Innate Immune System Cells in Non-Small Cell Lung Carcinoma
    Al-Shibli, K.
    Al-Saad, S.
    Donnem, T.
    Persson, M.
    Bremnes, R.
    Busund, L. T.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S263 - S263
  • [44] Prognostic Value of DNA Ploidy and Nucleotyping in Early-stage Non-small Cell Lung Cancer
    Mao, L.
    Wu, J.
    Lin, D.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S262 - S262
  • [45] Prognostic value of matrix metalloproteinase 9 expression in patients with non-small cell lung cancer
    Peng, Wen-Jia
    Zhang, Jun-Qing
    Wang, Bing-Xiang
    Pan, Hai-Feng
    Lu, Man-Man
    Wang, Jing
    CLINICA CHIMICA ACTA, 2012, 413 (13-14) : 1121 - 1126
  • [46] Prognostic value of hematological inflammatory markers in patients with non-small cell lung cancer.
    Kishi, N.
    Ogura, M.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S764 - S765
  • [47] Prognostic value of neutrophil to lymphocyte ratio in patients with advanced non-small cell lung cancer
    Koukidou, Sofia
    Charpidou, Andriani
    Vassos, Dimitrios
    Grapsa, Dimitra
    Ampelioti, Sevasti
    Dimakou, Ekaterini
    Bakakos, Petros
    Poulakou, Garyphallia
    Syrigos, Konstantinos
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [48] Prognostic value of selected platelet parameters of patients operated for non-small cell lung cancer
    Lochowski, Mariusz
    Rebowski, Marek
    Chalubinska-Fendler, Justyna
    Zawadzka, Izabela
    Lochowska, Barbara
    Cieslik-Wolski, Bartosz
    Kozak, Jozef
    JOURNAL OF THORACIC DISEASE, 2022, 14 (05) : 1374 - 1383
  • [49] Preoperative Prognostic Value of ImmuneInflammation Index in Patients with Operable Non-Small Cell Lung Cancer
    Fraile Olivero, C.
    Milla Collado, L.
    Mecho Carratala, M.
    Ojanguren Arranz, A.
    Trujillano Cabello, J.
    Cerdan Santacruz, C.
    Montesinos, M.
    Rombola, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S435 - S435
  • [50] The prognostic value and model construction of inflammatory markers for patients with non-small cell lung cancer
    Xu, Wanting
    Liu, Xinya
    Yan, Ci
    Abdurahmane, Gulinurayi
    Lazibiek, Jiayina
    Zhang, Yan
    Cao, Mingqin
    SCIENTIFIC REPORTS, 2024, 14 (01)